Do some implant too many defibrillators or others too few?

Europace

Volumn 11, Issue 8, 2009, Pages 982-984

  Israel, Carsten W ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; COMORBIDITY; DEFIBRILLATOR; DISEASE SEVERITY; EDITORIAL; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART PACING; HUMAN; IMPLANTATION; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; TREATMENT CONTRAINDICATION;

DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; REFERRAL AND CONSULTATION;

EID: 68649114572     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup207     Document Type: Editorial

References (13)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
4. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288-96.
5. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
6. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
7. Implant rates 2008. Eucomed, http://www.eucomed.be/press/downloads.aspx, accessed July 15th, 2009.
8. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med 2005;353:1471-80.
9. Parkes J, Chase DL, Grace A, Cunningham D, Roderick PJ. Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis. BMJ 2005;330;454-5.
10. Bradfield J, Warner A, Bersohn MM. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center. Pacing Clin Electrophysiol 2009;32:S194-7.
11. Borleffs CJW, Wilde AAM, Cramer MJM, Wever E, Mosterd A. Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation? Neth Heart J 2007;15:129-32.
12. Scott PA, Turner NG, Chung A, Morgan JM, Roberts PR. Varying implantable cardioverter defibrillator referral patterns from implanting and non-implanting hospitals. Europace 2009;11:1048-51.
13. Shah B, Hernandez AF, Liang L, Al-Khatib SM, Yancy CW, Fonarow GC et al. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure. J Am Coll Cardiol 2009;53:416-22.